LYSAKER, NORWAY--(Marketwire - November 27, 2007) - Pronova BioPharma ASA (OSE: PRON.OL) (“Pronova BioPharma” or the “Company”) announces that the Federal Patent Court in Munich, Germany, has today issued a decision by which Pronova BioPharma’s patent covering the Active Pharmaceutical Ingredient (“API”) of Omacor has been declared invalid in Germany. This decision follows the nullity action brought by KD Pharma Bexbach GmbH (“KD Pharma”) and Institute Biochimique SA (“IBSA”) against Pronova BioPharma in June 2006.
